Navigation Links
Artificial enzyme removes natural poison
Date:8/26/2010

For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables.

While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so-called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.

Proof of concept for artificial enzymes

Chemzymes are designed molecules emulating the targeting and efficiency of naturally occurring enzymes and the recently graduated Dr. Bjerre is pleased about her results.

"Showing that these molecules are capable of decomposing toxins required vast amounts of work and time. But it's been worth every minute because it proves the general point that it's possible to design artificial enzymes for this class of task", explains Bjerre.

Simple molecules performing complex tasks

Most people know enzymes as an ingredient in detergents. In our bodies enzymes are in charge of decomposing everything we eat, so that our bodies can absorb the nutrients. But they also decompose ingested toxins, ensuring that our bodies survive the encounter.

In several important aspects artificial enzymes function in the same way as naturally occurring ones. But where natural enzymes are big and complex, the artificial ones have been pared down to the basics.

The flat-nosed plier of the molecular world

One consequence of this is that designing chemzymes for targeted tasks ought to be easier. With fewer parts, there's less to go wrong when changing the structure of chemzymes. And for enzymes as well as for their artificial counterparts even small changes in structure will have massive consequences for functionality.

In this, enzymes are very much like hand-tools, where scissors and flat nosed pliers, though almost identical, have very different duties.

Hardwearing replacement enzymes

Even though naturally occurring enzymes are several orders of magnitude smaller than flat-nosed pliers, they are still unrivalled tools. Some of the fastest chemical reactions blast off when enzymes are added to the broth.

Several known enzymes in the body catalyze more than one million reactions per second when they decompose compounds. There's just one drawback to enzymes. They are extremely fragile.

If an enzyme in our body was to be warmed above sixtyfive degrees centigrade or subjected to organic solvents, they would immediately denature. They would unravel and stop functioning.

Taking the heat

So far no one has succeeded in designing chemzymes that are anywhere near as fast as their naturally occurring cousins. But they are far more resilient.

Manmade enzymes take on heat and solvents without batting a molecular eyelid. One of the consequences of this is that chemzymes can be mass-produced using industrial chemical processes. This is a huge advantage when you need a lot of product in a hurry.

Factory-made enzymes

Producing natural enzymes in industrial settings is considerably more time-consuming because they have to be grown. Rather like one grows apples or grain.

So the robust and designable compounds may turn out to be just what's needed for a wide variety of jobs. Not least in the pharmaceutical industries, where the need is massive for chemical compounds which can solve problems that no amount of designing could ever tweak the natural ones to work on, which are unaffected by industrial processes, and to top it of, cheap to produce.


'/>"/>

Contact: Jes Andersen
jean@science.ku.dk
453-050-6582
University of Copenhagen
Source:Eurekalert  

Related biology news :

1. Taking the next step toward advanced artificial limbs
2. Researchers design artificial cells that could power medical implants
3. Evolved Machines Selected as a Prime Contractor for DARPA Program to Engineer an Artificial Olfaction System
4. Scientists identify cell changes leading to impaired artificial kidney function
5. Biomedical researchers create artificial human bone marrow in a test tube
6. TECNALIA uses artificial vision to improve recycling of electronic scrap metal
7. Artificial cells, simple model for complex structure
8. Red pandas reveal an unexpected (artificial) sweet tooth
9. Development of an artificial simulator of the nervous system to do research into diseases
10. Non-wovens as scaffolds for artificial tissue
11. Progress toward artificial tissue?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial enzyme removes natural poison
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... the three months ended December 31, 2016. ... and diagnostics company that develops and commercializes proprietary technologies and ... ... the commercial milestones achieved in fiscal 2016," said Andrew ...
(Date:2/21/2017)... ... 21, 2017 , ... Genedata, a leading provider of advanced ... establishment of Genedata Limited as a new subsidiary in the United Kingdom. The ... science informatics. Creating the UK subsidiary reinforces Genedata’s commitment to collaborate closely with ...
(Date:2/21/2017)... IL (PRWEB) , ... February ... ... of the Life -Sciences division, Treximo will pair its $200M operational capacity ... results-based consulting and project management in areas affecting quality and operational management. ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017 /PRNewswire/ ... that apatorsen results from two randomized Phase 2 clinical trials ... 2017 Genitourinary Cancers Symposium, held February 16 th - 18 ... from trials in bladder and prostate cancers demonstrated apatorsen was ... standard-of-care treatments. ...
Breaking Biology Technology: